tradingkey.logo
搜索

EDAP TMS ADR Reptg 1 Ord Shs

FOCL
添加自选
3.245USD
-0.165-4.84%
收盘 11-13 16:00(美东)
149.12M总市值
0.00市盈率 TTM

EDAP TMS ADR Reptg 1 Ord Shs

3.245
-0.165-4.84%

关于 EDAP TMS ADR Reptg 1 Ord Shs 公司

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners

EDAP TMS ADR Reptg 1 Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

EDAP TMS ADR Reptg 1 Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.29M
+3.87%
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.29M
+3.87%
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.29M
+3.87%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
658.83K
+3.19%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
658.83K
+3.19%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
658.83K
+3.19%
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
15.10K
+66.23%
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
15.10K
+66.23%
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
15.10K
+66.23%
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
11.00K
-569.70%
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.29M
+3.87%
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.29M
+3.87%
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.29M
+3.87%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
658.83K
+3.19%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
658.83K
+3.19%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
658.83K
+3.19%

常见问题

EDAP TMS ADR Reptg 1 Ord Shs的前五大股东是谁?

EDAP TMS ADR Reptg 1 Ord Shs 的前五大股东如下:Dr. Lance Willsey
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有